Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/35971

1-Bromopropane: Target Organs and Levels of Evidence for TR-564

Toxicology and Carcinogenesis Studies of 1-Bromopropane (CAS No. 106-94-5) in F344/N Rats and B6C3F1 (Inhalation Studies)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
1-Bromopropane
106-94-5
11/19/2009Inhalation
R: 0, 125, 250, OR 500 PPM; M: 0, 62.5, 125, OR 250 PPM; 50/SEX/SPECIES/DOSE
Battelle Northwest Laboratory

Levels of Evidence

Male Rats: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Intestines: Large: Adenoma 0/50 0/50 2/50 1/50
  • Skin: Keratoacanthoma 0/50 3/50 6/50 6/50 keratoacanthoma or squamous cell carcinoma 1/50 4/50 6/50 8/50 keratoacanthoma, basal cell adenoma or carcinoma or squamous cell carcinoma 1/50 7/50 9/50 10/50
May Have Been Related
  • Mesothelium (Abdominal Cavity/Tunica Vaginalis): Malignant: 0/50 2/50 2/50 4/50
  • Pancreas Islet Cell: Adenoma 0/50 5/50 4/50 5/50
Non-Neoplastic Lesions
  • Nasal Cavity: Inflammation, suppurative, chronic; inflammation, chronic active; glands, hyperplasia
  • Larynx: Inflammation, chronic active
Female Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Intestines: Large: Adenoma 0/50 1/50 2/50 5/50
May Have Been Related
  • Skin: Squamous cell papilloma, keratoacanthoma, basal cell adenoma or carcinoma 1/50 1/50 1/50 4/50
Non-Neoplastic Lesions
  • Nasal Cavity: Inflammation, suppurative, chronic; inflammation, chronic active; glands, hyperplasia; respiratory epithelium, hyperplasia; olfactory epithelium metaplasia, respiratory
  • Larynx: Inflammation, chronic active; metaplasia, squamous
  • Trachea: Inflammation, chronic active; epithelium, hyperplasia
Male Mice: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • Lung: Bronchiole, vacuolization cytoplasmic; bronchiole regeneration
  • Nasal Cavity: Respiratory epithelium, vacuolization cytoplasmic; respiratory epithelium, hyperplasia; olfactory epithelium, metaplasia, respiratory
  • Trachea: Vacuolization cytoplasmic
Female Mice: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Lung: Alveolar/bronchiolar adenoma 1/50 6/50 4/50 10/50 alveolar/bronchiolar carcinoma 0/50 7/50 5/50 4/50 alveolar/bronchiolar adenoma or carcinoma 1/50 9/50 8/50 14/50
Non-Neoplastic Lesions
  • Lung: Bronchiole regeneration
  • Nasal Cavity: Respiratory epithelium, vacuolization cytoplasmic; respiratory epithelium, hyperplasia; olfactory epithelium, metaplasia, respiratory
  • Trachea: Vacuolization cytoplasmic
  • Larynx: Vacuolization cytoplasmic